Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.47
+0.27 (4.35%)
Nov 22, 2024, 4:00 PM EST - Market closed
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $213.94 million as of November 22, 2024. Its market cap has decreased by -20.11% in one year.
Market Cap
213.94M
Enterprise Value
67.32M
1-Year Change
-20.11%
Ranking
Category
Stock Price
$6.47
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has decreased from $271.36M to $213.94M, a decrease of -21.16%. That is a compound annual growth rate of -20.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2024 | 205.01M | -42.67% |
| Dec 29, 2023 | 357.58M | 31.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Utah Medical Products | 221.44M |
| Sera Prognostics | 220.87M |
| Orchestra BioMed Holdings | 219.34M |
| biote | 217.28M |
| Solid Biosciences | 216.15M |
| High Tide | 213.40M |
| Corbus Pharmaceuticals Holdings | 212.78M |
| SOPHiA GENETICS | 212.60M |